Press Releases

Gain insights into the cutting-edge innovation in in vivo and in vitro tumour modelling, discover strategies to de-risk your studies, and learn how to refine your drug development…
Read More...

With the 5th Genome Editing Therapeutics Summit just three weeks away, anticipation is building! On December 3-5, Gene Editing experts will join together to spearhead the development,…
Read More...

Taking place during the 15th World ADC San Diego, the  11th World ADC Awards reunited both newcomers and leaders of the antibody-drug conjugate industry this November 6, 2024.…
Read More...

This week marks your last chance to save up to $350 on your ticket to 5th Genome Editing Therapeutics Summit (formerly known as CRISPR 2.0). With industry giants like Beam,…
Read More...

In a few weeks’ time, industry’s foremost drug developers will be convening at the 5th Genome Editing Therapeutics Summit* (December 3-5 | Boston, MA), the only industry meeting…
Read More...

The 5th Genome Editing Therapeutics Summit (formerly the CRISPR 2.0 Summit) this December will be your foremost drug development focused gene editing meeting, providing you with the…
Read More...

Genome editing represents one of the most significant recent advancements in molecular biology. CRISPR/Cas9 has been seen by many as cutting-edge (if you can pardon the pun) for its…
Read More...

The toolbox of precision genome editing and delivery techniques continue to grow in 2024, enabling the community to make safer and more precise edits to a wider variety of disease…
Read More...

In December, 120 senior figures from industry and academia will be uniting at the foremost gene editing drug development meeting, the 5th Genome Editing Therapeutics Summit (formerly…
Read More...

Prepare for the definitive meeting dedicated to refining analytics to ensure the swift progression of highly efficacious products through IND and clinical trials, ultimately securing…
Read More...

Get ready for a revolutionary moment in the world of cell therapy as biotech trailblazers, big pharma, and immunology experts from around the globe gather at the 2nd Cell Therapy for…
Read More...

As BioNTech, Moderna, and Merck have recently released positive phase II clinical results for personalized cancer vaccines, the whole industry is now racing to develop affordable and…
Read More...

The race for clinical approval of TGF-β therapies is heating up, fueled by significant investments like Corbus Pharmaceuticals' recent $98.5 million and Biacara Therapeutics' $165…
Read More...

On October 15-16, 300+ leading pharma executives and patient advocates will come together inspire trust and amplify the patient voice. With it no longer being enough to just merely…
Read More...

Domestic and international markets in Asia surging as CPHI & PMEC China welcomes 60,000 attendees and 3500 exhibitors CPHI & PMEC China (June 19-21st) returns to the Shanghai…
Read More...

In the wake of significant achievements in synthetic peptide therapeutics, such as Novo Nordisk’s $6 billion peptide expansion, Merck’s advancements in macrocyclic peptides, and…
Read More...

The 4th Next Generation Gene Therapy Vectors Summit is just around the corner! Delivery is cited by many in the gene therapy field as the limiting factor for R&D progress. As such,…
Read More...

The future of peptide pharmaceuticals is evolving rapidly, with countless positive readouts, new collaborations and groundbreaking innovations in oral delivery in Q1 of 2024 alone.…
Read More...

The 6th CKD Drug Development Summit is just around the corner! This highly anticipated summit is set to bring together KOLs, industry experts, and regulators to concentrate kidney…
Read More...

The gene therapy landscape has witnessed an unprecedented surge in advancements, with more therapies gaining FDA approval in the past year than in the previous five years combined.…
Read More...